Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea - Concepedia

Concepedia

Publication | Open Access

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea

DOI Full Paper Access

13

Citations

50

References

2020

Year

Hye-Young Kim, Seong‐Beom Park, Eun‐Sil Kang, Sangmin Lee, Hyun-Jin Kim, Matt Wasserman

Human Vaccines & Immunotherapeutics

Abstract

A NIP using PCV13 was estimated to have a more substantial public health impact and be cost-saving compared to a program with PCV10 due to broader serotype coverage.

References

	Year	Citations

Page 1